	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	260.41	217.67	320.21	19.6%	-18.7%
Operating Profit Qtr	88.49	61.40	136.68	44.1%	-35.3%
Net Profit Qtr	63.58	44.06	95.74	44.3%	-33.6%
Earning Per Share Adjusted latest Qtr	6.08	4.21	9.15	44.4%	-33.6%

* Consolidated data

Detailed Results

Concord Biotech Ltd.

13 Nov 2025

1402.20

-0.67%

Board Meeting

Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

1. Approval of Q2 FY26 Financial results 2. Upon recommendation of Audit committee, board approved to Invest by way of acquiring 100 % equity share capital of M/s Celliimune Biotech Private Limited. 3. Upon recommendation of Audit committee, board approved invest upto Rs. 10 Crores in Captive Hybrid Solar Power Project for Limbasi Plant by entering into an agreement with relevant party.

pdf

Concord Biotech Ltd.

08 Nov 2025

1402.20

-0.67%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September, 2025, scheduled on Friday, 14th November, 2025 at 03:30 P.M. IST. The Earnings Call invite is enclosed for your records.

pdf

Concord Biotech Ltd.

08 Nov 2025

1402.20

-0.67%

Board Meeting

Concord Biotech Ltd - 543960 - Board Meeting Intimation for Financial Results

BSE India

Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2025.

pdf